Cargando…

Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study

The tumour-stroma ratio (TSR) and tumour budding (TB) are two high-risk factors with potential to be implemented in the next TNM classification. The aim of the current study was to evaluate the practical application of the two biomarkers based on reproducibility, independency and prognostic value. P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smit, Marloes A., van Pelt, Gabi W., Terpstra, Valeska, Putter, Hein, Tollenaar, Rob A. E. M., Mesker, Wilma E., van Krieken, J. Han J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589816/ https://www.ncbi.nlm.nih.gov/pubmed/34533595 http://dx.doi.org/10.1007/s00384-021-04023-4

Ejemplares similares

Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study
por: Smit, Marloes, et al.
Publicado: (2019)

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer
por: Zunder, Stéphanie M., et al.
Publicado: (2018)

The intra-tumoural stroma in patients with breast cancer increases with age
por: Vangangelt, Kiki M. H., et al.
Publicado: (2019)

e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study
por: Smit, Marloes A, et al.
Publicado: (2021)

The role of artificial intelligence to quantify the tumour-stroma ratio for survival in colorectal cancer
por: Smit, Marloes A, et al.
Publicado: (2020)

Deep learning based tumor–stroma ratio scoring in colon cancer correlates with microscopic assessment
por: Smit, Marloes A., et al.
Publicado: (2023)

Tumor stroma as contributing factor in the lymph node metastases process?
por: Mesker, Wilma E., et al.
Publicado: (2019)

Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer
por: Mesker, W E, et al.
Publicado: (2015)

The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review
por: Kramer, C. J. H., et al.
Publicado: (2018)

Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content
por: Sandberg, Tessa P., et al.
Publicado: (2018)

Erratum: Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content
por: Sandberg, Tessa P., et al.
Publicado: (2019)

The Stroma Liquid Biopsy Panel Contains a Stromal-Epithelial Gene Signature Ratio That Is Associated with the Histologic Tumor-Stroma Ratio and Predicts Survival in Colon Cancer
por: Ravensbergen, Cor J., et al.
Publicado: (2021)

The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer
por: Vangangelt, Kiki M.H., et al.
Publicado: (2020)

Tumour budding and tumour–stroma ratio in hepatocellular carcinoma
por: Kairaluoma, Valtteri, et al.
Publicado: (2020)

Standardization of the tumor-stroma ratio scoring method for breast cancer research
por: Hagenaars, Sophie C., et al.
Publicado: (2022)

Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer
por: Ravensbergen, Cor J., et al.
Publicado: (2021)

Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations
por: van Pelt, G. W., et al.
Publicado: (2018)

Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
por: Eriksen, Ann C., et al.
Publicado: (2018)

Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma
por: Vangangelt, K. M. H., et al.
Publicado: (2017)

Characteristics of tumour stroma in regional lymph node metastases in colorectal cancer patients: a theoretical framework for future diagnostic imaging with FAPI PET/CT
por: Polack, Meaghan, et al.
Publicado: (2022)

Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2‐negative early breast cancer
por: Hagenaars, Sophie C., et al.
Publicado: (2021)

Tumour‐stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case‐cohort study
por: Dang, Hao, et al.
Publicado: (2021)

Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer
por: Sandberg, Tessa P., et al.
Publicado: (2019)

The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
por: Eriksen, Ann Christina, et al.
Publicado: (2018)

Tumour-stroma ratio and prognosis in gastric adenocarcinoma
por: Kemi, Niko, et al.
Publicado: (2018)

Correlation of Immunological and Histopathological Features with Gene Expression-Based Classifiers in Colon Cancer Patients
por: van de Weerd, Simone, et al.
Publicado: (2022)

Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients
por: Mesker, Wilma E., et al.
Publicado: (2009)

Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study
por: Vogelaar, F. J., et al.
Publicado: (2016)

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer
por: van Pelt, G.W., et al.
Publicado: (2019)

The prognostic significance of tumour-stroma ratio in endometrial carcinoma
por: Panayiotou, Hannah, et al.
Publicado: (2015)

Prognostic significance of tumour stroma ratio in inflammatory breast cancer
por: Downey, Candice L, et al.
Publicado: (2015)

Gastric cancer nodal tumour–stroma ratios influence prognosis
por: Huang, J., et al.
Publicado: (2020)

N-Glycomic Signature of Stage II Colorectal Cancer and Its Association With the Tumor Microenvironment
por: Boyaval, Fanny, et al.
Publicado: (2021)

Hypoxic Signalling in Tumour Stroma
por: Laitala, Anu, et al.
Publicado: (2018)

The prognostic significance of tumour–stroma ratio in oestrogen receptor-positive breast cancer
por: Downey, C L, et al.
Publicado: (2014)

Reponse to: comment on, ‘Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'
por: Downey, C L, et al.
Publicado: (2015)

Epigenetic Mechanisms beyond Tumour–Stroma Crosstalk
por: Gagliano, Teresa, et al.
Publicado: (2021)

Tumour-stromal interactions: Phenotypic and genetic alterations in mammary stroma - implications for tumour progression
por: Schor, Seth L, et al.
Publicado: (2001)

N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression
por: Holst, Stephanie, et al.
Publicado: (2016)

Tumour-stromal interactions: Role of the stroma in mammary development
por: Silberstein, Gary B
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_0hg48rs024f7tpki7v769igb7b